[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80311]], camposKey:1424-8247 2023-04-01 Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 201900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75819]], camposKey:2574-3805 2023-01-13 Economic Burden of the 2020 COVID-19 Hospitalizations in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76540]], camposKey:0013-9351 2023-01-01 Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80753]], camposKey:2296-2565 2023-01-01 Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 202100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80313]], camposKey:1663-9812 2023-01-01 Medication economic burden of antidepressant non-adherence in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80752]], camposKey:2296-2565 2023-01-01 Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65058]], camposKey:1364-8535 2022-12-01 Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75668]], camposKey:1999-4923 2022-12-01 Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68805]], camposKey:1010-660X 2022-06-01 Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75592]], camposKey:2296-858X 2022-04-25 ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75112]], camposKey:0749-5161 2022-02-01 Pediatric Emergency Medicine Training A Survey of Current Status in Latin America00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82891]], camposKey:2308-3425 2021-12-01 A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65938]], camposKey:1664-3224 2021-10-13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82893]], camposKey:2296-858X 2021-06-15 Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58802]], camposKey:1661-7827 2021-05-02 Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83203]], camposKey:2077-0383 2021-05-01 HGF, IL-1¿, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61689]], camposKey:2296-858X 2021-01-01 Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61658]], camposKey:0020-7314 2021-01-01 Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76541]], camposKey:2077-0383 2021-01-01 Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58803]], camposKey:0767-3981 2021-01-01 Trends in the use of antihistamines with reference to drivers between 2015 and 2019: A population-based registry analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58793]], camposKey:0214-3429 2020-12-01 Trend in the use of topical ocular anti-infectives in a region of Spain between 2015 and 2019: a population-based registry study453458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52139]], camposKey:1747-597X 2020-01-01 Benzodiazepines in the oral fluid of Spanish drivers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65954]], camposKey:0214-4840 2020-01-01 DSM-5 in patients seeking their first treatment for alcohol use disorder. Sex differences in the multicenter CohRTA study136144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55559]], camposKey:0214-4840 2020-01-01 Dsm-5 in patients seeking their first treatment for alcohol use disorder. Sex differences in the multicenter cohrta study Dsm-5 en pacientes que solicitan el primer tratamiento del trastorno por uso de alcohol. Diferencias de sexo en el estudio multicéntrico cohrta136144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56392]], camposKey:1424-8247 2020-01-01 Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55558]], camposKey:0379-0738 2020-01-01 Prevalence of alcohol and other psychoactive substances in motor vehicle drivers in Spain, 2018: Cross-sectional dataset analysis with studies from 2008 and 201300, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77897]], camposKey:2227-9059 2020-01-01 ¿The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies¿.3550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55560]], camposKey:1424-8247 2020-01-01 Trends in antidepressants use in Spain between 2015 and 2018: Analyses from a population-based registry study with reference to driving00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52137]], camposKey:0001-4575 2020-01-01 Worldwide research output trends on drinking and driving from 1956 to 201500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49045]], camposKey:0268-1315 2019-01-01 Antipsychotics in the general population and the driver population: comparisons from a population-based registry study184188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48318]], camposKey:0022-3476 2019-01-01 Cerebral Oxygen Saturation and Negative Postoperative Behavioral Changes in Pediatric Surgery: A Prospective Observational Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49056]], camposKey:2045-2322 2019-01-01 Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49057]], camposKey:2044-6055 2019-01-01 Drivers who tested positive for cannabis in oral fluid: A longitudinal analysis of administrative data for Spain between 2011 and 201600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52130]], camposKey:2077-0383 2019-01-01 Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52132]], camposKey:2077-0383 2019-01-01 Nosocomial Vs. Community-Acquired Infective Endocarditis in Spain: Location, Trends, Clinical Presentation, Etiology, and Survival in the 21st Century00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52138]], camposKey:2077-0383 2019-01-01 The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 201800, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49023]], camposKey:0214-4840 2019-01-01 What to do when drivers test positive for methadone in roadside drug tests? The Spanish Experience ¿Que hacer en los casos que dan positivo a metadona en los controles de drogas en carretera? La experiencia de España324326, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58797]], camposKey:1353-8047 2018-11-01 CANNABIS IN ORAL FLUID OF SPANISH DRIVERS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58796]], camposKey:1353-8047 2018-11-01 METHADONE IN ORAL FLUID OF SPANISH DRIVERS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61699]], camposKey:2077-0383 2018-01-01 Correction of hyponatremia may be a treatment stratification biomarker: A two-stage systematic review and meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50818]], camposKey:0007-1323 2018-01-01 CURRENT SITUATION OF THE SURGICAL TREATMENT IN INFECTIVE ENDOCARDITIS PATIENTS IN SPAIN60, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49058]], camposKey:2352-3409 2018-01-01 Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation25672575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48504]], camposKey:0884-8734 2018-01-01 Evolution of the Incidence, Mortality, and Cost of Infective Endocarditis in Spain Between 1997 and 201416101613, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55077]], camposKey:0025-7753 2018-01-01 Impact of an ultraviolet air sterilizer on cardiac surgery patients, a randomized clinical trial299307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37972]], camposKey:0025-7753 2018-01-01 Impact of an ultraviolet air sterilizer on cardiac surgery patients, a randomized clinical trial Impacto de un esterilizador ultravioleta en pacientes de cirugía cardíaca: ensayo clínico aleatorizado299307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37970]], camposKey:0376-8716 2018-01-01 Opioids in oral fluid of Spanish drivers3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49046]], camposKey:0214-4840 2018-01-01 Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study292299, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48321]], camposKey:1569-9293 2018-01-01 Surgery for acute infective endocarditis: Epidemiological data from a Spanish nationwide hospital-based registry498504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49024]], camposKey:1567-5769 2018-01-01 The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review483492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37971]], camposKey:1663-9812 2018-01-01 The problem of benzodiazepine use and its extent in the driver population: A population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30495]], camposKey:1663-9812 2017-01-01 Effects of intensive control of glycemia on clinical kidney outcomes in type 2 diabetes patients compared with standard control: A meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32531]], camposKey:0954-0121 2017-01-01 HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study15511556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48875]], camposKey:0007-1323 2017-01-01 Incorporating preoperative variables into the EUROSCORE I increases its ability to predict preoperative risk89, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30497]], camposKey:0022-4804 2017-01-01 Procalcitonin and white blood cells, combined predictors of infection in cardiac surgery patients187194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48874]], camposKey:0007-1323 2017-01-01 Reducing postoperative infection in cardiac surgery by using new disinfection technologies80, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37964]], camposKey:1747-597X 2017-01-01 Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30496]], camposKey:1664-0640 2017-01-01 Treatment of comorbid alcohol dependence and anxiety disorder: Review of the scientific evidence and recommendations for treatment00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49047]], camposKey:2044-6055 2017-01-01 Use of driving-impairing medicines by a Spanish population: a population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30498]], camposKey:2110-5820 2016-01-01 Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30499]], camposKey:1473-7175 2016-01-01 Parkinson´s disease, antiparkinson medicines, and driving10231032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30501]], camposKey:0883-9441 2016-01-01 Predicting cardiac surgery-associated acute kidney injury: The CRATE score130138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30500]], camposKey:0883-9441 2016-01-01 Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury233239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30503]], camposKey:0955-3959 2015-01-01 Alcohol and drug use by Spanish drivers: Comparison of two cross-sectional road-side surveys (2008-9/2013)794797, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49025]], camposKey:0214-4840 2015-01-01 Drugs, substance use disorder and driving: Intervention of health professionals in the treatment of addictions Drogas, Trastorno por Uso de Sustancias y Conducción: La intervención de los profesionales que trabajan en adicciones161167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30502]], camposKey:1364-8535 2015-01-01 Erratum to: Development of the Post Cardiac Surgery (POCAS) prognostic score [Crit Care. 2013;17:R209]00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30506]], camposKey:1082-6084 2014-01-01 Comparative study of the perceived quality of life of patients in treatment for cocaine and heroin dependence in spain: Differences by gender and time in treatment13531358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55567]], camposKey:0210-5691 2014-01-01 Retos asistenciales en la atención al paciente traumatizado en España. La necesidad de implementación de la evidencia científica incluyendo la prevención secundaria. Challenges in care of trauma patient in Spain. The need for implementation of scientific evidence including secondary prevention386390, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30505]], camposKey:0376-8716 2014-01-01 The relationship between observed signs of impairment and THC concentration in oral fluid231238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30504]], camposKey:1473-7175 2014-01-01 The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders849865, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30507]], camposKey:1364-8535 2013-01-01 Development of the Post Cardiac Surgery (POCAS) prognostic score110, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30508]], camposKey:1747-597X 2013-01-01 Driving and legal status of Spanish opioid-dependent patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30510]], camposKey:0001-4575 2013-01-01 Road rage among drug dependent patients848853, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30511]], camposKey:0145-6008 2013-01-01 Scientific Publications and Research Groups on Alcohol Consumption and Related Problems Worldwide: Authorship Analysis of Papers Indexed in PubMed and Scopus Databases (2005 to 2009)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30509]], camposKey:0001-4575 2013-01-01 The Spanish pictogram on medicines and driving: The population's comprehension of and attitudes towards its use on medication packaging10561061, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30512]], camposKey:0306-5251 2012-01-01 A European approach to categorizing medicines for fitness to drive: Outcomes of the DRUID project920931, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6701]], camposKey:0883-9441 2012-01-01 Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30515]], camposKey:1471-2458 2012-01-01 Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: A multi-country survey00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30513]], camposKey:0379-0738 2012-01-01 Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: A roadside study106113, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30514]], camposKey:0883-9441 2012-01-01 Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery1825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30517]], camposKey:1937-1888 2011-01-01 Alcohol use, illicit drug use, and road rage185193, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22060]], camposKey:0213-7615 2011-01-01 Drogas ilegales, alcohol y agresividad vial271284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20882]], camposKey:0300-8932 2011-01-01 El polimorfismo R753Q del toll-like receptor 2 se asocia a un aumento en el riesgo de sufrir endocarditis infecciosa10561059, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30516]], camposKey:1749-8090 2011-01-01 Intraoperative PaO2 is not related to the development of surgical site infections after major cardiac surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49026]], camposKey:1575-0973 2011-01-01 Neuroscience and addiction Neurociencias y Adicción4142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32548]], camposKey:0394-9508 2011-01-01 Risk factors for surgical site infections after major cardiac surgery207212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48357]], camposKey:0300-8932 2011-01-01 Toll-like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis El polimorfismo R753Q del toll-like receptor 2 se asocia a un aumento en el riesgo de sufrir endocarditis infecciosa10561059, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30518]], camposKey:1538-9588 2010-01-01 Accident rates for drug-dependent patients in treatment for substance dependence: A pilot trial460465, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22058]], camposKey:0213-9111 2010-01-01 Agresividad vial en la población general423427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30522]], camposKey:1575-0973 2010-01-01 Are anticonvulsants effective in the treatment of cocaine dependence? ¿son eficaces los anticonvulsivantes en el tratamiento de la dependencia a cocaína?470, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49027]], camposKey:1575-0973 2010-01-01 Collaboration between Primary Health Care and speciallized health care in the assessment, management and referal of patients with alcohol related problems La colaboración entre Atención Primaria y atención especializada en el abordaje y derivación de los pacientes con problemas relacionados con el alcohol56, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30521]], camposKey:0955-3959 2010-01-01 Differences in alcohol-related mortality between foreign-born and native-born Spaniards240243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22056]], camposKey:0025-7753 2010-01-01 Drogas ilegales y conducción de vehículos549551, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22053]], camposKey:0212-6567 2010-01-01 Mortalidad prematura y años potenciales de vida perdidos relacionados con el consumo de alcohol en España y en las comunidades autónomas en el año 200495101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30519]], camposKey:1082-6084 2010-01-01 Perception and consumption of alcohol among the immigrant population from latin America in valencia region (Spain)25672578, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30523]], camposKey:0001-4575 2010-01-01 Predictors of driving after alcohol and drug use among adolescents in Valencia (Spain)20242029, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30520]], camposKey:1356-1294 2010-01-01 Self-reported drug allergies and the diagnostic work-up in the surgical population902904, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49031]], camposKey:1575-0973 2009-01-01 Buprenorphine-naloxone: New for 2009 Buprenorfina-naloxona: Lo nuevo de 2009247251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30525]], camposKey:0021-9509 2009-01-01 Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass687694, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49029]], camposKey:1575-0973 2009-01-01 Internet course on clinical cases of addictive disorders and the treatment of addictions, second edition Curso de la red de trastornos adictivos de casos clínicos en el tratamiento de las adicciones, segunda edición8384, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30526]], camposKey:1538-9588 2009-01-01 Letter to the editor9899, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49028]], camposKey:1575-0973 2009-01-01 Male alcohol and cannabis consumer: Treatment in outpatient rehabilitation centre Varón consumidor de alcohol y cannabis: Tratamiento en un centro de rehabilitación ambulatorio180190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32550]], camposKey:1538-9588 2009-01-01 Medical condition and sudden death while driving.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22031]], camposKey:1139-8264 2009-01-01 Profilaxis antibiótica en cirugía cardíaca: Análisis de los factores de riesgo de infección6977, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32549]], camposKey:0218-4923 2009-01-01 Risk factors for mediastinitis and endocarditis after cardiac surgery612616, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49030]], camposKey:1575-0973 2009-01-01 Where and how to publish on addictions Dónde y cómo publicar en Adicciones1011, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49033]], camposKey:1575-0973 2008-01-01 Alcohol and allergy Alcohol y alergia7576, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49034]], camposKey:1575-0973 2008-01-01 Alcohol, risk consumption, impulsiveness and development of alcohol dependence Alcohol, consumo de riesgo, impulsividad y desarrollo de dependencia del alcohol224225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30531]], camposKey:0034-9356 2008-01-01 Central venous pressure, rewarming time, and total fluid replacement volume are predictors of mortality and complications after cardiac surgery Presión venosa central, tiempo de recalentamiento y líquidos totales son factores postoperatorios de morbi-mortalidad en cirugía cardiaca.605609, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30527]], camposKey:0022-5223 2008-01-01 Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery15221527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20872]], camposKey:0025-7753 2008-01-01 Efecto de la simvastatina en la concentración de las proteínas de fase aguda después de la cirugía cardíaca773775, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20874]], camposKey:1139-8264 2008-01-01 Efecto del purgado de la bomba de circulación extracorpórea con coloides o cristaloides sobre la concentración de las proteínas de fase aguda después de la cirugía cardíaca2632, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49032]], camposKey:1134-5934 2008-01-01 Fitness to drive among patients with mental disorders. Their assessment in medical centers for drivers Aptitud para conducir de los pacientes con trastornos mentales. Su evaluación en los centros de reconocimiento de conductores6372, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22038]], camposKey:0014-2565 2008-01-01 Mortalidad relacionada con el consumo de alcohol en España y en las comunidades autónomas en el año 2004455462, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22035]], camposKey:0025-7753 2008-01-01 Mortalidad y mortalidad prematura relacionadas con el consumo de alcohol en España entre 1999 y 20041013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30530]], camposKey:0001-4575 2008-01-01 Older drivers, medical condition, medical impairment and crash risk5560, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30529]], camposKey:1538-9588 2008-01-01 Patients treated with obstructive sleep apnea syndrome and fitness to drive assessment in clinical practice in Spain at the medical traffic centers168172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49035]], camposKey:1575-0973 2008-01-01 Pharmacological aspects of the buprenorphine-naloxona treatment programmes Aspectos farmacológicos de los programas de tratamiento con buprenorfina-naloxona116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20875]], camposKey:1139-8264 2008-01-01 Síndrome de respuesta inflamatoria sistémica (SRIS) y cirugía cardíaca bajo circulación extracorporea (Parte I)153156, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30528]], camposKey:0001-5172 2008-01-01 The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass12041212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30532]], camposKey:1346-9843 2007-01-01 Assessment of fitness to drive and cardiovascular diseases at the Spanish medical traffic centres18001804, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30534]], camposKey:0379-0738 2007-01-01 Cannabis and driving: Results from a general population survey111116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20879]], camposKey:1139-8264 2007-01-01 Factores postoperatorios predictores de morbimortalidad en cirugía cardiaca8386, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49036]], camposKey:0210-0010 2007-01-01 Fitness to drive assessment in drivers with neurological disorders at the medical driver test centres Evaluación en los centros de reconocimiento de conductores de los pacientes con patología neurológica y neuromuscular526531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49037]], camposKey:1575-0973 2007-01-01 On the standardization of terminology in substance abuse field Sobre la estandarización de la terminología en relación con las drogas de abuso245246, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30533]], camposKey:1575-0973 2007-01-01 The presence of alcohol in the human body: Alcohol in hair, and continuous transdermal alcohol monitoring Alcohol y su presencia en el cuerpo humano: El caso del alcohol y el pelo, y la monitorización transdermal continua del alcohol170171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49039]], camposKey:1575-0973 2007-01-01 Tobacco, health and smoking cessation treatment Tabaco, salud y el tratamiento del tabaquismo45, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49038]], camposKey:1575-0973 2007-01-01 Treatments of patients with dual diagnosis Tratamientos de los pacientes con patología dual7374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22042]], camposKey:1575-0973 2006-01-01 Alcohol y salud: nuevas evidencias2110, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30540]], camposKey:0145-6008 2006-01-01 Alcohol-related social consequences in Castille and Leon, Spain656664, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30541]], camposKey:1082-6084 2006-01-01 Demand for prior treatment in alcoholic patients6169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22049]], camposKey:1575-0973 2006-01-01 Información para los lectores y autores de Trastornos Adictivos: listas de comprobación para autores, revisores y editores de revistas médicas7577, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22044]], camposKey:1575-0973 2006-01-01 Joven con consumo de alcohol y cannabis y accidente de tráfico1421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30543]], camposKey:0213-9111 2006-01-01 Motor vehicle crash fatalities at 30 days in Spain Fallecidos a 30 días por leslones producidas an accidente de tráfico en España108115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30539]], camposKey:0105-4538 2006-01-01 Prevalence of positive prick test to anaesthetic drugs in the surgical population952953, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30537]], camposKey:0306-5251 2006-01-01 Prevalence of positive prick test to neuromuscular blocking drugs in the surgical population [3]506507, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30538]], camposKey:0025-7753 2006-01-01 Prevalence of the positive prick-test with latex in patients subjected to surgical intervention Prevalencia de prick-test positivo a látex en pacientes sometidos a intervención quirúrgica4750, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30535]], camposKey:0265-0215 2006-01-01 Prick-test evaluation to anaesthetics in patients attending a general allergy clinic10311036, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30542]], camposKey:0001-4575 2006-01-01 Road traffic accidents among alcohol-dependent patients: The effect of treatment201207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22048]], camposKey:1575-0973 2006-01-01 Tratamiento del alcoholismo: resultados del estudio COMBINE y la práctica clínica diaria145147, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30536]], camposKey:0306-5251 2006-01-01 Warfarin, medicinal drugs and road traffic accidents [1]627628, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22052]], camposKey:0465-546X 2005-01-01 Alcohol y prevención de los problemas relacionados con el consumo de alcohol en el ámbito laboral6572, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30545]], camposKey:0025-7753 2005-01-01 Are we making proper use of vancomcycin in clinical practice? [1] ¿Se utiliza adecuadamente la vancomicina en la práctica clínica?396397, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30544]], camposKey:0965-2140 2005-01-01 Buprenorphine prescription and the increased relative cost [4]13731374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22047]], camposKey:1575-0973 2005-01-01 Condiciones de prescripción y financiación de la buprenorfina-Subutex según la autorización de comercialización en España de 2000 a 20043743, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22043]], camposKey:1575-0973 2005-01-01 La investigación cooperativa: la Red de Trastornos Adictivos123125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20878]], camposKey:1139-8264 2005-01-01 Pacientes alérgicos a fármacos en el ámbito de quirófano137140, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49041]], camposKey:1138-3593 2005-01-01 Prevention of injuries derived from traffic collisions La prevención de las lesiones derivadas de las colisiones de tráfico151153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49040]], camposKey:0214-4840 2005-01-01 Trends in alcohol consumption among spaniards between 1993, 1995 and 1997, from national health survey data Evolución del consumo de alcohol de los españoles entre 1993, 1995 y 1997, a partir de los datos de la encuesta nacional de salud1727, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22045]], camposKey:1575-0973 2005-01-01 Varón dependiente del alcohol235243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30546]], camposKey:0265-0215 2004-01-01 An assessment of compliance with surgical prophylaxis protocols in a hospital [6]923925, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30549]], camposKey:0965-2140 2003-01-01 Current initiatives in drug abuse research in Spain.8610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30547]], camposKey:1053-8569 2003-01-01 Medication and fitness to drive389394, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30548]], camposKey:0165-6147 2003-01-01 Pitfalls in estimating drug-related crash risk [2] (multiple letters)114115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49050]], camposKey:0165-6147 2003-01-01 Response to Ramaekers: Pitfalls in estimating drug-related crash risk115115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30552]], camposKey:0379-0738 2002-01-01 Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991and 20006370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46155]], camposKey:1575-0973 2002-01-01 Alcohol y accidentes laborales en España: revisión bibliográfica, 1995-2001244255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30553]], camposKey:0741-8329 2002-01-01 Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines?3134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30555]], camposKey:0096-882X 2002-01-01 Drinking habits throughout the seasons of the year in the Spanish population577580, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30551]], camposKey:0165-6147 2002-01-01 Medicinal drugs and driving: From research to clinical practice441443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30550]], camposKey:0965-2140 2002-01-01 Spain: youth, leisure, and alcohol consumption.12321236, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32529]], camposKey:1053-0770 2002-01-01 What is the optimal morphine dose to be administered intrathecally in postoperative analgesia of cardiac surgery?132134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30557]], camposKey:0376-8716 2001-09-01 Illicit drugs and fitness to drive: Assessment in Spanish Medical Driving Test Centres1925, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46158]], camposKey:1575-0973 2001-01-01 Alcohol y accidentes de tráfico: ¿Prevenir qué?172180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30558]], camposKey:0735-0414 2001-01-01 Alcohol-related problems and fitness to drive256261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30556]], camposKey:0021-9509 2001-01-01 Bilateral diaphragmatic paralysis after open heart surgery785786, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46157]], camposKey:1575-0973 2001-01-01 George Estievenart, Observatorio Europeo de la Droga y las ToXIcomanías (OEDT)8084, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49176]], camposKey:1575-0973 2001-01-01 Las desintoXIcaciones ultrarrápidas: tipos y modos de realización1420, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46159]], camposKey:1575-0973 2001-01-01 Población heroinómana tratada con metadona y/o naltrexona: análisis de similitudes y diferencias288288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22063]], camposKey:1133-1674 2000-01-01 Acerca de las desintoxicaciones ultrarrápidas11, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22073]], camposKey:0213-7615 2000-01-01 Alcohol y accidentes de tráfico: ¿Hemos progresado en estos últimos 25 años?377384, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30560]], camposKey:0376-8716 2000-01-01 Presence of illegal drugs in drivers involved in fatal road traffic accidents in Spain177182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30559]], camposKey:0895-7061 2000-01-01 The use of antihypertensive therapy in Spain (1986-1994)607610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30562]], camposKey:0025-7753 1999-01-01 Alcohol and road accidents: the physicians' role in their prevention Alcohol y accidentes de tráfico: el papel de los médicos en su prevención.256258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30561]], camposKey:0379-0738 1999-01-01 Alcohol use among fatally injured drivers in Spain117125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81408]], camposKey:0025-7753 1999-01-01 Alcohol y accidentes de tráfico: el papel de los médicos en su prevención256258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30565]], camposKey:0007-0912 1999-01-01 Allergy to anaesthetizing agents in Spain336337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30566]], camposKey:1082-6084 1999-01-01 Illegal drug-using trends among students in a Spanish university in the last decade (1984-1994)12811297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30564]], camposKey:1082-6084 1999-01-01 Substance use by Spanish university students11851192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30563]], camposKey:0965-2140 1999-01-01 Ultrarapid opiate detoxification: A look at what is happening in Spain [1]12391240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22065]], camposKey:0213-7615 1998-01-01 Acamprosato, naltrexona y el tratamiento de la dependencia al alcohol13, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22066]], camposKey:0213-7615 1998-01-01 Desintoxicaciones ultracortas: del triunfo de la farmacología a la innovación tecnologica197199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22068]], camposKey:0210-6523 1998-01-01 Nuevas estrategias en el tratamiento de la dependencia al alcohol y a las drogas ilegales163169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30567]], camposKey:1053-8569 1997-01-01 The use of medication by the Spanish population4148, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30568]], camposKey:0379-0355 1996-12-01 Effect of several antidepressant drugs on isolated rat vas deferens in vitro507511, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30570]], camposKey:0025-7753 1996-10-26 MDMA o éxtasis: Aspectos farmacológicos, toxicológicos y clínicos549555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30571]], camposKey:0269-8951 1996-08-07 Effect of amineptine on different preparations of isolated guinea-pig and rat organ445446, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30575]], camposKey:0025-7753 1996-04-20 The European plan of action concerning alcohol consumption: a look to the future Plan europeo de actuación sobre el consumo de alcohol: una mirada hacia el futuro.581582, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30578]], camposKey:0140-6736 1996-01-01 Alcohol and driving985986, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30579]], camposKey:0213-9111 1996-01-01 Alcohol, health and society: European charter on alcohol Alcohol, salud y sociedad: la carta Europea sobre alcohol.197199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30572]], camposKey:0210-5705 1996-01-01 Consumption of drugs for the digestive system and for the metabolism by the Spanish population: study from the Health National Survey in 1987 and 1993 El consumo de fármacos del aparato digestivo y metabolismo por la población española: estudio a partir de la Encuesta Nacional de Salud de 1987 y 1993.347350, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30569]], camposKey:0212-6567 1996-01-01 Contraceptive use and smoking among Spanish women Consumo de anticonceptivos y hábito tabáquico en las mujeres españolas.442445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22070]], camposKey:0210-6523 1996-01-01 Gasto farmacéutico, consumo de fármacos y el uso racional de medicamentos5362, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30577]], camposKey:0040-5957 1996-01-01 LES PRESCRIPTIONS DE BENZODIAZEPINES DANS L'ENVIRONNEMENT SANITAIRE EN ESPAGNE
How benzodiazepines are prescribed in a primary health care setting in Spain185189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30574]], camposKey:1053-8569 1996-01-01 Medication use by the driving population255261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30580]], camposKey:0213-9111 1996-01-01 Mortality related to alcohol consumption in Spain: 1981-1990 Mortalidad relacionada con el consumo de alcohol en España: 1981-1990.161168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30573]], camposKey:0212-6567 1996-01-01 The evolution of pharmaceutical services and drug consumption in Spain Evolución de la prestación farmacéutica y del consumo de medicamentos en España.148149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30576]], camposKey:0306-5251 1996-01-01 The use of medication and alcohol among the Spanish population253255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30588]], camposKey:0145-6008 1995-01-01 Beverage Effects on Patterns of Alcohol Consumption15831586, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30586]], camposKey:0001-5172 1995-01-01 Comparison of the recovery characteristics of midazolam, alone or antagonised with flumazenil, and thiopental in ASA III-IV patients186190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30587]], camposKey:0096-882X 1995-01-01 Drinking and driving in Spain403407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22062]], camposKey:1130-8427 1995-01-01 El consumo de medicamentos en la población española: Encuesta Nacional de Salud de España, 19937784, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30583]], camposKey:0376-8716 1995-01-01 Illegal drug taking and driving: patterns of drug taking among Spanish drivers8386, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30584]], camposKey:0345-5564 1995-01-01 Illegal drugs and driving15, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32551]], camposKey:0345-5564 1995-01-01 Prescribing medication for the driver: The role of health professionals123128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30585]], camposKey:0965-2140 1995-01-01 The harmful effects of drugs as perceived by the Spanish public11131116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30582]], camposKey:1135-5727 1995-01-01 The presence of pathological processes among spanish drivers: its relevance to road safety Presencia de procesos patológicos en los conductores españoles: su relevancia en el campo de la seguridad vial.499508, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30581]], camposKey:0025-7753 1995-01-01 Traffic accidents in the Spanish population Accidentes de tráfico en la población española.601604, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22064]], camposKey:0213-7615 1994-01-01 Drogas, drogodependencias y seguridad vial281285, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30590]], camposKey:0140-6736 1994-01-01 Drugs and driving2820, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13253]], camposKey:0210-8348 1994-01-01 Efecto del pirlindol en diversas preparaciones de órgano aislado de cobaya y rata4954, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22069]], camposKey:0210-6523 1994-01-01 El uso de medicamentos en la población191201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22028]], camposKey:1130-8427 1994-01-01 Fármacos y conducción de vehículos137144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30591]], camposKey:0145-6008 1994-01-01 Gender Differences in Patterns of Alcohol Consumption in Spain13421347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30589]], camposKey:0392-2990 1994-01-01 Patterns of smoking in Spain - Results from a regional general population survey595598, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30592]], camposKey:0096-882X 1994-01-01 Screening for problem drinkers in a general population survey in Spain by use of the CAGE scale471474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20880]], camposKey:0210-6523 1994-01-01 Técnicas y aspectos farmacológicos de la Anestesia en Cirugía Vascular3543, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30598]], camposKey:0145-6008 1993-01-01 Alcohol-Related Mortality in Spain253255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30599]], camposKey:0034-9356 1993-01-01 Cardiorespiratory evaluation of midazolam and thiopental in ASA IV patients undergoing translumbar aortography in prone position EVALUACION CARDIORRESPIRATORIA DEL MIDAZOLAM Y TIOPENTAL DURANTE SU EMPLEO EN LA AORTOGRAFIA TRANSLUMBAR, Y EN PACIENTES EN DECUBITO PRONO Y ASA IV119124, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30594]], camposKey:0140-6736 1993-01-01 Decreasing prevalence of smoking in Spain1190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30595]], camposKey:0965-2140 1993-01-01 Drug abuse related emergency room episodes in United States and in Spain281283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22071]], camposKey:0210-6523 1993-01-01 Los hábitos de vida saludable en Castilla y León233244, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30597]], camposKey:0735-0414 1993-01-01 Patterns of alcohol consumption among the general population of castile and leon (spain4354, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30596]], camposKey:0345-5564 1993-01-01 Patterns of, and attituts towards, drinking alcohol and driving among Spanish drivers115119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30605]], camposKey:0379-0738 1992-01-01 Drugs and alcohol consumption amongst Spanish drivers221225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13308]], camposKey:0210-6523 1992-01-01 Efectos de fármacos antidepresivos sobre conducto deferente aislado de rata163165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30602]], camposKey:0379-0355 1992-01-01 Effect of psychotropic drugs on histamine H2-receptors in rat isolated uterus431435, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30607]], camposKey:0213-9111 1992-01-01 El Hábito Enólico en el Medio Hospitalario de Valladolid143144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20242]], camposKey:0210-6523 1992-01-01 El hábito tabáquico en Castilla y León151161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30601]], camposKey:0212-6052 1992-01-01 Guidelines for the treatment of reflux esophagitis PAUTAS DE TRATAMIENTO DEL REFLUJO GASTROESOFAGICO Y ESOFAGITIS7178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30603]], camposKey:0306-4522 1992-01-01 Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindol317327, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30606]], camposKey:0040-5957 1992-01-01 Patterns of drug consumption among Spanish drivers6366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30604]], camposKey:0952-0481 1992-01-01 Patterns of drug use in Castille and Leon (Spain)11531160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30600]], camposKey:0212-6052 1992-01-01 Pharmacological principles in the treatment of asthma BASES FARMACOLOGICAS DE LA TERAPEUTICA ANTIASMATICA98113, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30609]], camposKey:0735-0414 1991-01-01 Alcohol consumption in young adults in the rural communities of spain93101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46114]], camposKey:0210-6523 1991-01-01 Drogodependencias en Castilla y León7386, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32552]], camposKey:1130-4588 1991-01-01 Gastroesophageal reflux (II). Management trends REFLUJO GASTROESOFAGICO Y ESOFAGITIS (II). PAUTAS DE TRATAMIENTO416423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30610]], camposKey:0269-8951 1991-01-01 'Illegal' drugs and driving in Spain491492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30608]], camposKey:0398-7620 1991-01-01 The alcoholic habit in the spanish hospital environment.421423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30611]], camposKey:0952-0481 1991-01-01 Trends in alcohol consumption in Spain104105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44634]], camposKey:0210-6523 1991-01-01 Un programa de microordenador para el análisis del antagonismo competitivo de fármacos712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46154]], camposKey:0210-6523 1990-01-01 Alcohol y alcoholismo en Castilla y León153171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30613]], camposKey:0079-6123 1990-01-01 Chapter 27 Cholinergic receptors in the rat and human brain: Microscopic visualization243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30612]], camposKey:0034-9356 1990-01-01 Midazolam: Pharmacologic and clinical aspects MIDAZOLAM: ASPECTOS FARMACOLOGICOS Y CLINICOS8194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30614]], camposKey:0398-7620 1989-12-01 Knowledge about and attitudes towards drinking among university students in Spain345352, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30615]], camposKey:0735-0414 1989-12-01 Patterns of alcohol use among university students in spain465471, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30616]], camposKey:0952-0481 1989-01-01 Patterns of Drug Use by Young People in the Rural Community of Spain647652, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30619]], camposKey:0031-7012 1988-01-01 Blockade of muscarinic, histamine h<inf>1</inf> and histamine h<inf>2</inf> receptors by antidepressants225231, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30617]], camposKey:0952-0481 1988-01-01 Drug Consumption Among University Students in Spain9198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30618]], camposKey:0269-8951 1988-01-01 Prevalence of smoking among young people in the rural community of Spain947948, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30621]], camposKey:0300-5771 1987-01-01 Tobacco Consumption Among Spanish university students294295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30620]], camposKey:0379-8305 1987-01-01 Verapamil and nifedipine effect on K+-induced contractions of guinea pig ileum during postnatal development449453, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30622]], camposKey:0034-5164 1986-12-01 Effects of verapamil on acetylcholine and field stimulation induced contraction in postnatal development of guinea-pig ileum257260, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30624]], camposKey:0376-8716 1986-01-01 Alcohol consumption among University students in Spain4149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30625]], camposKey:0021-793X 1986-01-01 Effects of antidepressants on histamine H1 and muscarinic acetylcholine receptors in guinea-pig ileum149154, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30623]], camposKey:0021-793X 1986-01-01 Effects of antidepressants on histamine H2 receptors in isolated rat uterus351354, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30627]], camposKey:0031-6989 1985-01-01 Effect of aluminum chloride on ascending colon of the rat11211127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32553]], camposKey:0305-6651 1985-01-01 Effect of loperamide and non-steroid anti-inflammatory drugs on water, glucose and electrolyte transport in the small intestine of the rat in vivo2470, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30628]], camposKey:0034-9437 1985-01-01 Effect of some calcium antagonists on guinea-pig ileum muscular activity ACCION DE ALGUNOS ANTAGONISTAS DEL CALCIO SOBRE LA ACTIVIDAD MUSCULAR DEL ILEON DE COBAYO405408, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30626]], camposKey:0034-9402 1985-01-01 Effect of trazodone on oxidative metabolism of rat brain. In vitro201206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30630]], camposKey:0021-793X 1984-01-01 Anticholinergic action of neuroleptics and antidepressants on guinea-pig ileum. Comparison with atropine and pirenzepine ACTION ANTICHOLINERGIQUE DES NEUROLEPTIQUES ET DES ANTIDEPRESSEURS SUR L'ILEON DE COBAYE. COMPARAISON AVEC L'ATROPINE ET LA PIRENZEPINE177184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40917]], camposKey:0305-6651 1984-01-01 Effect of etomidate on oxidative metabolism of rat brain in vitro11550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30629]], camposKey:0004-0576 1984-01-01 Effect of hemineurine on the oxidative metabolism of rat tissues in vitro EFECTO DE LA HEMINEURINA SOBRE EL METABOLISMO OXIDATIVO DE DIVERSOS TEJIDOS DE RATA IN VITRO3744, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30633]], camposKey:0304-8616 1983-01-01 Comparative study of trazodone and imipramine against acetylcholine and electrical stimulation on guinea pig ileum ANALISIS COMPARATIVO DE TRAZODONE E IMIPRAMINA FRENTE A ACETILCOLINA Y ESTIMULO ELECTRICO EN EL ILEON AISLADO DE COBAYO263268, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30632]], camposKey:0304-8616 1983-01-01 The effect of etomidate sulfate on the activity oxidative of rat kidney, liver and heart 'in vitro' EFECTO DEL SULFATO DE ETOMIDATO SOBRE LA ACTIVIDAD OXIDATIVA DE HIGADO, RINON Y CORAZON DE RATA 'IN VITRO'269274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30634]], camposKey:0304-8616 1982-01-01 Effect of etomidate on oxidative metabolism and ATPase activity of rat brain in vitro EFECTO DEL ETOMIDATO SOBRE EL METABOLISMO OXIDATIVO Y ACTIVIDAD ATPASE DE CEREBRO DE RATA IN VITRO237238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30635]], camposKey:0304-8616 1982-01-01 Effect of etomidate sulfate on oxidative activity in vitro of rat liver, kidney and heart EFECTO DEL SULFATO DE ETOMIDATO SOBRE LA ACTIVIDAD OXIDATIVA DE HIGADO, RINON Y CORAZON DE RATA IN VITRO239240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30636]], camposKey:0304-8616 1982-01-01 Effect of trazodone HCl on oxidative metabolism and ATPase activity of rat brain in vitro EFECTO DEL CLORHIDRATO DE TRAZODONE SOBRE EL METABOLISMO OXIDATIVO Y ACTIVIDAD ATPASA DE CEREBRO DE RATA IN VITRO147150][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33999]},camposKey: 287 La elaboración de flashcards como herramienta de innovación docente para la enseñanza de la farmacología. 978-84-09-48185-9Libro de actas del Congreso Universitario Internacional sobre Comunicación, Innovación, Investigación y Docencia: CUICIID 2023 1 2023-01-01 Fórum Internacional de Comunicación y Relaciones públicas (Fórum XXI), CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33707]},camposKey: 153 177 Measurements of Calcium in Chromaffin Cell Organelles Using Targeted Aequorins 978-1-0716-2671-9Chromaffin Cells: Methods and Protocols 1 2023-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17506]},camposKey: 121 134 Prescribing and dispensing guidelines for medicinal drugs affecting driving performance 978-376439922-1Drugs, Driving and Traffic Safety 1 2009-01-01 Birkhäuser Basel, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=16899]},camposKey: 226 231 6.4.2. Epidemiología del cannabis 8479031646Tratado S.E.T. de Trastornos Adictivos 1 2006-01-01 Editorial Médica Panamericana , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=16898]},camposKey: 416 418 9.2.8. Farmacología de la buprenorfina 8479031646Tratado S.E.T. de Trastornos Adictivos 1 2006-01-01 Editorial Médica Panamericana ][com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2370]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2371]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2369]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2372]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2373]]][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=106396],camposKey=978-84-9089-002-8Responsabilidad y consecuencias ante el volante del drogodependiente y del consumidor ocasional: VII debates en drogodependencias 1 2014-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=106394],camposKey=978-84-8484-337-5Accidentalidad en drogodependientes: V debates en drogodependencias : 7 julio de 2010 1 2011-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=118827],camposKey=8460807010Alcohol, drogas, medicamentos y lesiones por colisiones de tráfico 1 2007-01-01 Universidad de Valladolid}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=106395],camposKey=84-609-7809-5Ageing, mental illness and medical diseases: a synthesis of results 1 2005-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=106392],camposKey=84-8448-217-0Pautas de consumo de medicamentos, alcohol y drogas en los conductores españoles 1 2003-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=105645],camposKey=84-7846-292-9El consumo de drogas en Castilla y León, 1992 1 1994-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=106393],camposKey=84-7762-429-1Los estudiantes universitarios de Valladolid ante las drogas 1 1994-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102220],camposKey=84-86251-86-9Compendio de psiconeurofarmacología 1 1988-01-01 Díaz de Santos}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102216],camposKey=84-398-9580-1Farmacoterapia del aparato digestivo 1 1987-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102214],camposKey=84-86192-79-XLas drogas y los universitarios de Valladolid 1 1986-01-01 }][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30936]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30804]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30425]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30438]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633779]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628794]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639494]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626078]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624948]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2133318991]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624835]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629361]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628574]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626684]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625861]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626760]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=69870]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624891]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624906]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626827]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626823]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626761]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@e664622, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4818bb44, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@20208bdf, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5de29233, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@610998fb, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6c46dd05, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@481cdd21, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@126ad1b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2c452384, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@76b16dfc][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dee0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dcd7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d9f9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63de61, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d522, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d6ba, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d520, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63eb07, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d553, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375255, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d6e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d6ed, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e8e0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e026, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e680, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e1aa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e14e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e24c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e163, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e83d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e748, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e768, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e118, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e767, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e11c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e8b3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e11e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e91e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e365, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5fb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5b6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5c2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d7ce, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e92e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e372, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5cc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e937, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e54a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e89f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dbf6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3739a2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373edd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d5ff, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d5fe, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ea00, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ba5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e565, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63daa6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63df22, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63df23, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d873, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d872, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3726a3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37224c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e7d3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3726b1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e582, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ec21, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ec63, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d49, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e4ce, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a4e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a44, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372c64, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a45, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37521b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bd9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bdb][][][][][com.sigma.fs3.argos.domain.gpc.GpcExpGestionId[id=com.sigma.fs3.argos.domain.gpc.GpcExpGestionIdPK[ifcactivitat=EXP, ifccomptador=482]]][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1188]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c12b9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bb18e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c12ba], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bb18d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@464003], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@464002], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467be0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45ee85], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@464004], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45ee83], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f64a], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45ee86], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45eee5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4646d0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45ee84], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4133b1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c2a01], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f8c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c2a09], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4121c9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460703], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f74], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41222a], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41282f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411e40], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f43b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c2927], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f376], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f353]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17051, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17044, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17025, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d9e, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16de5, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d84, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15d84, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@151eb, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@137b0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@137af][]